Dr Chantal   Kopecky
Postdoctoral Fellow

Dr Chantal Kopecky

2018: Promotion to Lecturer, UNSW Sydney

2015: PhD in Immunology, Medical University of Vienna, Austria

2009: MSc in Nutrition Science, University of Vienna, Austria

Science
School of Chemistry

I obtained my PhD in Immunology at the Medical University of Vienna, Austria in the field of cardiovascular and lipoprotein biology in chronic kidney disease. Extending my work in Austria as junior Post-doctoral Fellow my research was further focused on linking molecular changes in lipid quality with clinical outcomes in cardiovascular high-risk patient populations.

After moving to Sydney in 2016, I was investigating metabolic and inflammatory complications in diabetes and cardiovascular disease at UNSW. Specifically, I utilised 3D lightsheet fluorescence imaging to visualise pathologic processes, immune cell involvement and disease progression in atherosclerosis and I was working on characterising impairments of skeletal muscle metabolism in the context of diabetes.

Working in the Pancreatic Cancer Translational Research Group at UNSW from 2018 - 2020, my research was focused on efficacy of drug delivery and novel therapeutic approaches in pancreatic cancer. Specific projects were aimed to investigate therapeutic targets to metabolically reprogramm the stroma in pancreatic cancer and the development of novel nanomedicines to deliver gene therapeutics to pancreatic tumours.

Currently, I am working in the field of Biomaterials and Tissue Engineering (Kilian Lab UNSW) with a specific focus on cancer mechanobiology and the development of novel 3D tumour micorenvironments.

Location
Hilmer Building Level 7 Sydney NSW 2052

Publications

  • Journal articles | 2021
    Dr Chantal Kopecky
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, vol. 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496
    Journal articles | 2021
    Dr Chantal Kopecky
    Kokkinos J; Ignacio RM; Haghighi K; Kopecky C; Sharbeen G; Gonzales-Aloy E; Youkhana J; Butler L; Goldstein D; McCarroll J; Phillips P, 2021, 'Patient-derived pancreatic tumours in a dish: implications for real-time precision medicine', HPB, vol. 23, pp. S235 - S235, http://dx.doi.org/10.1016/j.hpb.2020.11.590
    Journal articles | 2021
    Dr Chantal Kopecky
    Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, vol. 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0
    Journal articles | 2020
    Dr Chantal Kopecky
    Kokkinos J; Ignacio RMC; Sharbeen G; Boyer C; Gonzales-Aloy E; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs', Biomaterials, vol. 240, pp. 119742, http://dx.doi.org/10.1016/j.biomaterials.2019.119742
    Journal articles | 2020
    Dr Chantal Kopecky
    Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Berlakovich G; Kain R; Stegbauer J; Rahman M; Hellinger R; Gruber C; Grobe N; Fajkovic H; Eskandary F; Böhmig GA; Säemann MD; Kovarik JJ, 2020, 'Critical role of neprilysin in kidney angiotensin metabolism', Circulation Research, pp. 593 - 606, http://dx.doi.org/10.1161/CIRCRESAHA.119.316151
    Journal articles | 2019
    Dr Chantal Kopecky
    Schwaiger E; Burghart L; Signorini L; Ristl R; Kopecky C; Tura A; Pacini G; Wrba T; Antlanger M; Schmaldienst S; Werzowa J; Säemann MD; Hecking M, 2019, 'Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety.', Am J Transplant, vol. 19, pp. 907 - 919, http://dx.doi.org/10.1111/ajt.15223
    Journal articles | 2019
    Dr Chantal Kopecky
    Kopecky C; Lytvyn Y; Domenig O; Antlanger M; Kovarik JJ; Kaltenecker CC; Poglitsch M; Perkins BA; Rye KA; Cherney DZI; Säemann MD, 2019, 'Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus', Diabetologia, vol. 62, pp. 1090 - 1093, http://dx.doi.org/10.1007/s00125-019-4871-8
    Journal articles | 2019
    Dr Chantal Kopecky
    Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye KA; Cochran BJ, 2019, 'Translocator protein localises to CD11b + macrophages in atherosclerosis', Atherosclerosis, vol. 284, pp. 153 - 159, http://dx.doi.org/10.1016/j.atherosclerosis.2019.03.011
    Journal articles | 2019
    Dr Chantal Kopecky
    Kovarik JJ; Kaltenecker CC; Kopecky C; Domenig O; Antlanger M; Werzowa J; Eskandary F; Kain R; Poglitsch M; Schmaldienst S; Böhmig GA; Säemann MD, 2019, 'Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation', Scientific Reports, vol. 9, http://dx.doi.org/10.1038/s41598-019-46114-x
    Journal articles | 2019
    Dr Chantal Kopecky
    Raupachova J; Kopecky C; Cohen G, 2019, 'High-density lipoprotein from chronic kidney disease patients modulates polymorphonuclear leukocytes', Toxins, vol. 11, http://dx.doi.org/10.3390/toxins11020073
    Journal articles | 2018
    Dr Chantal Kopecky
    Werzowa JM; Säemann MD; Mohl A; Bergmann M; Kaltenecker CC; Brozek W; Thomas A; Haidinger M; Antlanger M; Kovarik JJ; Kopecky C; Song PXK; Budde K; Pascual J; Hecking M, 2018, 'A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.', PLoS One, vol. 13, pp. e0193569, http://dx.doi.org/10.1371/journal.pone.0193569
    Journal articles | 2018
    Dr Chantal Kopecky
    Reinthaler EM; Graf E; Zrzavy T; Wieland T; Hotzy C; Kopecky C; Pferschy S; Schmied C; Leutmezer F; Keilani M; Lill CM; Hoffjan S; Epplen JT; Zettl UK; Hecker M; Deutschländer A; Meuth SG; Ahram M; Mustafa B; El-Khateeb M; Vilariño-Güell C; Sadovnick AD; Zimprich F; Tomkinson B; Strom T; Kristoferitsch W; Lassmann H; Zimprich A, 2018, 'TPP2 mutation associated with sterile brain inflammation mimicking MS.', Neurol Genet, vol. 4, pp. e285, http://dx.doi.org/10.1212/NXG.0000000000000285
    Journal articles | 2017
    Dr Chantal Kopecky
    Antlanger M; Bernhofer S; Kovarik JJ; Kopecky C; Kaltenecker CC; Domenig O; Poglitsch M; Säemann MD, 2017, 'Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.', Ann Med, vol. 49, pp. 525 - 533, http://dx.doi.org/10.1080/07853890.2017.1313447
    Journal articles | 2017
    Dr Chantal Kopecky
    Kopecky C; Ebtehaj S; Genser B; Drechsler C; Krane V; Antlanger M; Kovarik JJ; Kaltenecker CC; Parvizi M; Wanner C; Weichhart T; Säemann MD; Tietge UJF, 2017, 'HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.', J Am Soc Nephrol, vol. 28, pp. 769 - 775, http://dx.doi.org/10.1681/ASN.2016030262
    Journal articles | 2017
    Dr Chantal Kopecky
    Antlanger M; Domenig O; Kovarik JJ; Kaltenecker CC; Kopecky C; Poglitsch M; Säemann MD, 2017, 'Molecular remodeling of the renin-angiotensin system after kidney transplantation.', J Renin Angiotensin Aldosterone Syst, vol. 18, pp. 1470320317705232, http://dx.doi.org/10.1177/1470320317705232
    Journal articles | 2017
    Dr Chantal Kopecky
    Antlanger M; Aschauer S; Kopecky C; Hecking M; Kovarik JJ; Werzowa J; Mascherbauer J; Genser B; Säemann MD; Bonderman D, 2017, 'Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis.', Kidney Blood Press Res, vol. 42, pp. 165 - 176, http://dx.doi.org/10.1159/000473868
    Journal articles | 2017
    Dr Chantal Kopecky
    Kovarik JJ; Kopecky C; Antlanger M; Domenig O; Kaltenecker CC; Werzowa J; Hecking M; Mahr S; Grömmer M; Wallner C; Aumayr K; Kain R; Zuckermann A; Poglitsch M; Säemann MD, 2017, 'Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.', J Heart Lung Transplant, vol. 36, pp. 355 - 365, http://dx.doi.org/10.1016/j.healun.2016.08.022
    Journal articles | 2017
    Dr Chantal Kopecky
    Kopecky C; Michlits G; Säemann MD; Weichhart T, 2017, 'Pro- versus Anti-inflammatory Actions of HDLs in Innate Immunity', Cell Metabolism, vol. 26, pp. 2 - 3, http://dx.doi.org/10.1016/j.cmet.2017.04.007
    Journal articles | 2017
    Dr Chantal Kopecky
    Sponder M; Kopecky C; Campean I-A; Emich M; Fritzer-Szekeres M; Litschauer B; Graf S; Säemann MD; Strametz-Juranek J, 2017, 'Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B.', Int J Med Sci, vol. 14, pp. 1040 - 1048, http://dx.doi.org/10.7150/ijms.20388
    Journal articles | 2017
    Dr Chantal Kopecky
    Sponder M; Kopecky C; Campean IA; Emich M; Bergler-Klein J; Graf S; Saeemann M; Strametz-Juranek J, 2017, 'P5311Influence of physical activity on hdl-quality reflected by serum amyloid a and surfactant protein b', European Heart Journal, vol. 38, http://dx.doi.org/10.1093/eurheartj/ehx493.p5311
    Journal articles | 2016
    Dr Chantal Kopecky
    Kovarik JJ; Antlanger M; Domenig O; Kaltenecker CC; Hecking M; Haidinger M; Werzowa J; Kopecky C; Säemann MD, 2016, 'Molecular regulation of the renin-angiotensin system in haemodialysis patients.', Nephrol Dial Transplant, vol. 31, pp. 851, http://dx.doi.org/10.1093/ndt/gfw071
    Journal articles | 2016
    Dr Chantal Kopecky
    Ebtehaj S; Kopecky C; Genser B; Drechsler C; Krane V; Antlanger M; J. Kovarik J; C. Kaltenecker C; Parvizi M; Wanner C; Weichhart T; Säemann MD; Tietge UJ, 2016, 'Abstract 622: High-density Lipoprotein Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, http://dx.doi.org/10.1161/atvb.36.suppl_1.622
    Journal articles | 2016
    Dr Chantal Kopecky
    Kovarik JJ; Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Kain R; Eskandary F; Böhmig GA; Säemann MD, 2016, 'MO020CHYMASE AND NEPRILYSIN ARE KEY REGULATORS OF THE CLASSICAL AND ALTERNATIVE RENIN ANGIOTENSIN SYSTEM (RAS) AFTER KIDNEY TRANSPLANTATION: IMPLICATIONS FOR RAS BLOCKINGTHERAPY', Nephrology Dialysis Transplantation, vol. 31, pp. i36 - i36, http://dx.doi.org/10.1093/ndt/gfw133.02
    Journal articles | 2016
    Dr Chantal Kopecky
    Kopecky C; Ebtehaj S; Genser B; Wanner C; Säemann MD; Tietge U, 2016, 'SP479HDL CHOLESTEROL EFFLUX IS NOT PREDICTIVE OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS ON HEMODIALYSIS', Nephrology Dialysis Transplantation, vol. 31, pp. i253 - i253, http://dx.doi.org/10.1093/ndt/gfw172.19
    Journal articles | 2016
    Dr Chantal Kopecky
    Kopecky C; Tufaro C; Antlanger M; Säemann MD; Bonderman D, 2016, 'SP485HDL PROTEIN COMPOSITION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND END STAGE RENAL DISEASE', Nephrology Dialysis Transplantation, vol. 31, pp. i255 - i255, http://dx.doi.org/10.1093/ndt/gfw172.25
    Journal articles | 2016
    Dr Chantal Kopecky
    Antlanger M; Domenig O; Kovarik JJ; Kaltenecker CC; Kopecky C; Poglitsch M; Säemann MD, 2016, 'MP012MOLECULAR REMODELING OF THE RENIN ANGIOTENSIN SYSTEM FOLLOWING RENAL TRANSPLANTATION', Nephrology Dialysis Transplantation, vol. 31, pp. i347 - i347, http://dx.doi.org/10.1093/ndt/gfw181.12
    Journal articles | 2016
    Dr Chantal Kopecky
    Kopecky C; Ebtehaj S; Genser B; Wanner C; Saemann MD; Tietge U, 2016, 'HDL cholesterol efflux is not predictive of cardiovascular risk in diabetic patients on hemodialysis', Atherosclerosis, vol. 252, pp. e107 - e107, http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.594
    Journal articles | 2015
    Dr Chantal Kopecky
    Kane JP; Malloy MJ; Pullinger CR, 2015, 'HDL cholesterol efflux capacity and cardiovascular events.', N Engl J Med, vol. 372, pp. 1871, http://dx.doi.org/10.1056/NEJMc1503139
    Journal articles | 2015
    Dr Chantal Kopecky
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T, 2015, 'Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.', Clin J Am Soc Nephrol, vol. 10, pp. 224 - 231, http://dx.doi.org/10.2215/CJN.06560714
    Journal articles | 2015
    Dr Chantal Kopecky
    Zewinger S; Drechsler C; Kleber ME; Dressel A; Riffel J; Triem S; Lehmann M; Kopecky C; Säemann MD; Lepper PM; Silbernagel G; Scharnagl H; Ritsch A; Thorand B; de las Heras Gala T; Wagenpfeil S; Koenig W; Peters A; Laufs U; Wanner C; Fliser D; Speer T; März W, 2015, 'Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.', Eur Heart J, vol. 36, pp. 3007 - 3016, http://dx.doi.org/10.1093/eurheartj/ehv352
    Journal articles | 2015
    Dr Chantal Kopecky
    Haidinger M; Antlanger M; Kopecky C; Kovarik JJ; Säemann MD; Werzowa J, 2015, 'Post-transplantation diabetes mellitus: evaluation of treatment strategies.', Clin Transplant, vol. 29, pp. 415 - 424, http://dx.doi.org/10.1111/ctr.12541
    Journal articles | 2015
    Dr Chantal Kopecky
    Kovarik JJ; Antlanger M; Domenig O; Kaltenecker CC; Hecking M; Haidinger M; Werzowa J; Kopecky C; Säemann MD, 2015, 'Molecular regulation of the renin-angiotensin system in haemodialysis patients.', Nephrol Dial Transplant, vol. 30, pp. 115 - 123, http://dx.doi.org/10.1093/ndt/gfu265
    Journal articles | 2015
    Dr Chantal Kopecky
    Holzer M; Schilcher G; Curcic S; Trieb M; Ljubojevic S; Stojakovic T; Scharnagl H; Kopecky CM; Rosenkranz AR; Heinemann A; Marsche G, 2015, 'Dialysis Modalities and HDL Composition and Function.', J Am Soc Nephrol, vol. 26, pp. 2267 - 2276, http://dx.doi.org/10.1681/ASN.2014030309
    Journal articles | 2015
    Dr Chantal Kopecky
    Kopecky C; Haidinger M; Birner-Grünberger R; Darnhofer B; Kaltenecker CC; Marsche G; Holzer M; Weichhart T; Antlanger M; Kovarik JJ; Werzowa J; Hecking M; Säemann MD, 2015, 'Restoration of renal function does not correct impairment of uremic HDL properties.', J Am Soc Nephrol, vol. 26, pp. 565 - 575, http://dx.doi.org/10.1681/ASN.2013111219
    Journal articles | 2015
    Dr Chantal Kopecky
    Kovarik JJ; Kopecky C; Antlanger M; Domenig O; Kaltenecker CC; Werzowa J; Hecking M; Mahr S; Zuckermann A; Kain R; Poglitsch M; Säemann MD, 2015, 'FP274ACE-INDEPENDENT RAS ENZYME ACTIVITIES IN HEART TRANSPLANT PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)', Nephrology Dialysis Transplantation, vol. 30, pp. iii158 - iii159, http://dx.doi.org/10.1093/ndt/gfv174.09
    Journal articles | 2015
    Dr Chantal Kopecky
    Antlanger M; Aschauer S; Kopecky C; Mascherbauer J; Bonderman D; Säemann M, 2015, 'FP608HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION IN HEMODIALYSIS PATIENTS: DIAGNOSIS, PREVALENCE AND ASSOCIATED FACTORS', Nephrology Dialysis Transplantation, vol. 30, pp. iii276 - iii276, http://dx.doi.org/10.1093/ndt/gfv181.01
    Journal articles | 2015
    Dr Chantal Kopecky
    Zewinger S; Speer T; Drechsler C; Kleber ME; Dressel A; Riffel J; Lehmann M; Kopecky C; Säemann MD; Lepper PM; Silbernagel G; Scharnagl H; Ritsch A; Laufs U; Wanner C; Fliser D; März W, 2015, 'FO005SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS', Nephrology Dialysis Transplantation, vol. 30, pp. iii2 - iii2, http://dx.doi.org/10.1093/ndt/gfv135.05
    Journal articles | 2015
    Dr Chantal Kopecky
    Kovarik JJ; Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Werzowa J; Hecking M; Poglitsch M; Kain R; Eskandary F; Böhmig GA; Säemann MD, 2015, 'FP842EVIDENCE FOR AN ACE-INDEPENDENT TISSUE-SPECIFIC RAS REGULATION AFTER KIDNEY TRANSPLANTATION', Nephrology Dialysis Transplantation, vol. 30, pp. iii359 - iii359, http://dx.doi.org/10.1093/ndt/gfv185.31
    Journal articles | 2015
    Dr Chantal Kopecky
    Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Manzel A; Linker R; Kain R; Säemann MD; Kovarik JJ, 2015, 'SP056OF MICE AND MEN: COMPARATIVE ANALYSIS OF ANGIOTENSIN FORMATION IN HEALTHY HUMAN AND MURINE KIDNEYS', Nephrology Dialysis Transplantation, vol. 30, pp. iii398 - iii399, http://dx.doi.org/10.1093/ndt/gfv188.19
    Journal articles | 2015
    Dr Chantal Kopecky
    Kovarik JJ; Kopecky C; Antlanger M; Domenig O; Kaltenecker CC; Werzowa J; Hecking M; Mahr S; Kain R; Zuckermann A; Poglitsch M; Säemann MD, 2015, 'PP.39.20', Journal of Hypertension, vol. 33, pp. e490 - e490, http://dx.doi.org/10.1097/01.hjh.0000468932.96228.ff
    Journal articles | 2015
    Dr Chantal Kopecky
    Kopecky C; Genser B; März W; Wanner C; Säemann MD; Weichhart T, 2015, 'HDL-Proteine sind mit kardiovaskulärem Risiko und Mortalität bei Patienten mit Typ 2-Diabetes an der Hämodialyse assoziiert', Nieren- und Hochdruckkrankheiten, vol. 44, pp. 159 - 165, http://dx.doi.org/10.5414/nhx01694
    Journal articles | 2015
    Dr Chantal Kopecky
    Kaltenecker C; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Kain R; Säemann MD; Kovarik JJ, 2015, 'PP.39.21', Journal of Hypertension, vol. 33, pp. e490 - e490, http://dx.doi.org/10.1097/01.hjh.0000468933.96228.b6
    Journal articles | 2015
    Dr Chantal Kopecky
    Kovarik JJ; Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Kain R; Eskandary F; Böhmig GA; Säemann MD, 2015, '8D.03', Journal of Hypertension, vol. 33, pp. e113 - e114, http://dx.doi.org/10.1097/01.hjh.0000467657.23414.54
    Journal articles | 2014
    Dr Chantal Kopecky
    Bajari TM; Winnicki W; Gensberger E-T; Scharrer SI; Regele H; Aumayr K; Kopecky C; Gmeiner BM; Hermann M; Zeillinger R; Sengölge G, 2014, 'Known players, new interplay in atherogenesis: Chronic shear stress and carbamylated-LDL induce and modulate expression of atherogenic LR11 in human coronary artery endothelium.', Thromb Haemost, vol. 111, pp. 323 - 332, http://dx.doi.org/10.1160/TH12-12-0924
    Journal articles | 2014
    Dr Chantal Kopecky
    Haidinger M; Werzowa J; Hecking M; Antlanger M; Stemer G; Pleiner J; Kopecky C; Kovarik JJ; Döller D; Pacini G; Säemann MD, 2014, 'Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.', Am J Transplant, vol. 14, pp. 115 - 123, http://dx.doi.org/10.1111/ajt.12518
    Journal articles | 2014
    Dr Chantal Kopecky
    Kopecky C; Michael H; Birner-Gruenberger R; Christopher K; Gunther M; Saemann M, 2014, 'Molecular Composition and Function of High-Density Lipoprotein Is Uniquely Altered After Kidney Transplantation.', Transplantation, vol. 98, pp. 565 - 565, http://dx.doi.org/10.1097/00007890-201407151-01897
    Journal articles | 2013
    Dr Chantal Kopecky
    Haidinger M; Werzowa J; Kain R; Antlanger M; Hecking M; Pfaffenberger S; Mascherbauer J; Gremmel T; Gilbertson JA; Rowczenio D; Weichhart T; Kopecky C; Hörl WH; Hawkins PN; Säemann MD, 2013, 'Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.', Amyloid, vol. 20, pp. 72 - 79, http://dx.doi.org/10.3109/13506129.2013.781998
    Journal articles | 2013
    Dr Chantal Kopecky
    Porrini E; Silva I; Ibernon M; Rocio B; Diaz JM; Delgado Mallen P; Osorio JM; Moreso F; Torres A; Haidinger M; Werzowa J; Hecking M; Stemer G; Pleiner J; Kopecky C; Pacini G; Antlanger M; Saemann MD, 2013, 'Management of diabetes in advanced CKD', Nephrology Dialysis Transplantation, vol. 28, pp. i77 - i77, http://dx.doi.org/10.1093/ndt/gft190
    Journal articles | 2012
    Dr Chantal Kopecky
    Atamaniuk J; Kopecky C; Skoupy S; Säemann MD; Weichhart T, 2012, 'Apoptotic cell-free DNA promotes inflammation in haemodialysis patients.', Nephrol Dial Transplant, vol. 27, pp. 902 - 905, http://dx.doi.org/10.1093/ndt/gfr695
    Journal articles | 2012
    Dr Chantal Kopecky
    Weichhart T; Kopecky C; Kubicek M; Haidinger M; Doller D; Katholnig K; Suarna C; Eller P; Tolle M; Gerner C; Zlabinger GJ; Van der giet M; Horl W; Stocker R; Saemann M, 2012, 'Serum amyloid A in uremic HDL promotes inflammation.', Journal of the American Society of Nephrology, vol. 23, pp. 934 - 947, http://dx.doi.org/10.1681/ASN.2011070668
    Journal articles | 2012
    Dr Chantal Kopecky
    Weichhart T; Kopecky C; Kubicek M; Haidinger M; Döller D; Katholnig K; Suarna C; Eller P; Tölle M; Gerner C; Zlabinger GJ; Van Der Giet M; Hörl WH; Stocker R; Säemann MD, 2012, 'When "good" cholesterol becomes bad', Vasomed, vol. 24, pp. 95 - 96
    Journal articles | 2011
    Dr Chantal Kopecky
    Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD, 2011, 'Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.', Blood, vol. 117, pp. 4273 - 4283, http://dx.doi.org/10.1182/blood-2010-09-310888
    Journal articles | 2010
    Dr Chantal Kopecky
    Säemann MD; Poglitsch M; Kopecky C; Haidinger M; Hörl WH; Weichhart T, 2010, 'The versatility of HDL: a crucial anti-inflammatory regulator.', Eur J Clin Invest, vol. 40, pp. 1131 - 1143, http://dx.doi.org/10.1111/j.1365-2362.2010.02361.x
  • Conference Presentations | 2019
    Dr Chantal Kopecky
    Tan WT; Kopecky C; Manandhar B; Rye K-A; Cochran B, 2019, 'Skeletal Muscle Specific Deletion Of Abca1 And Abcg1 Impacts Body Composition And Metabolism And Is Age Dependent', presented at 87th European Atherosclerosis Society Congress, 26 May 2019, http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.122
    Conference Papers | 2018
    Dr Chantal Kopecky
    Kopecky CM; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye KA; Cochran BJ, 2018, 'Translocator Protein as Novel Marker for Early Atherosclerosis', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, presented at Scientific Sessions of the American-Heart-Association on Vascular Discovery - From Genes to Medicine, San Francisco, CA, 10 May 2018 - 12 May 2018, http://dx.doi.org/10.1161/atvb.38.suppl_1.222
    Conference Abstracts | 2018
    Dr Chantal Kopecky
    Kopecky C; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye K-A; Cochran BJ, 2018, 'THE TSPO RADIOLIGAND 18F-PBR111 AS A PRE-ATHEROSCLEROTIC LESION DETECTION AGENT', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Toronto, CANADA, Vol. 32, pp. 145 - 146, presented at International Symposium on Atherosclerosis (ISA), Toronto, CANADA, 09 June 2018 - 12 June 2018, http://dx.doi.org/10.1016/j.atherosclerosissup.2018.04.446

Awards

  1. UNSW Sydney School of Medical Sciences Paper of the Month award (2019)
  2. Travel grant of the Australian Atherosclerosis Society (2018)
  3. Abstract Prize of the Austrian Diabetes Society (2017)
  4. Young Investigator Fellowship of the European Society of Atherosclerosis (2016)
  5. Clinical Science award of the Austrian Society of Transplantation, Transfusion and Genetics (2015)
  6. Hans-Krister-Stummvoll prize of the Austrian Society of Nephrology (2014)

Grants

2020 – 2021: Innovative nanomedicines to improve drug delivery and metabolic reprogramming in pancreatic cancer; Cancer Clinical Academic Group E/MCR Seed grant scheme (Primary Investigator)

2019 - 2021: MyoRobot automated Biomechatronics Technology for Higher Education and Teaching Using Virtual Skills Lab; Australia-Germany Joint Research Cooperation Scheme (Secondary Investigator)

2016 - 2020: Effect of empagliflozin on the renin-angiotensin system in patients with chronic kidney disease with and without type 2 diabetes (NCT03078101); Boehringer-Ingelheim Investigator-Initiated Study (Applicant and Secondary Investigator)

Media